P86.02 Pyrotinib Combined with Apatinib for HER2-Mutant Non-Small Cell Lung Cancer: Interim Analysis from a Phase II Clinical Study

Authors :: Guangjian Yang
F. Xu
L. Yang
Sizhong Zhang
X. Ai
Y. F. Wang
Huanfang Xu
Yunpeng Yang
Hui Li
Source :: Journal of Thoracic Oncology. 16:S672-S673
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Pulmonary and Respiratory Medicine
business.industry
Mutant
medicine.disease
Interim analysis
Clinical study
chemistry.chemical_compound
Oncology
chemistry
Phase (matter)
medicine
Cancer research
Apatinib
Non small cell
Lung cancer
business

Full Text Access

Tools